{'52WeekChange': None,
 'SandP52WeekChange': None,
 'address1': "1305 O'Brien Drive",
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 3.65,
 'askSize': 800,
 'averageDailyVolume10Day': 1188525,
 'averageVolume': 1271852,
 'averageVolume10days': 1188525,
 'beta': 1.684593,
 'beta3Year': None,
 'bid': 3.64,
 'bidSize': 1000,
 'bookValue': 0.392,
 'category': None,
 'circulatingSupply': None,
 'city': 'Menlo Park',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 3.9,
 'dayLow': 3.64,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -6.102,
 'enterpriseToRevenue': 5.142,
 'enterpriseValue': 463087296,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 3.7705715,
 'fiftyTwoWeekHigh': 5.94,
 'fiftyTwoWeekLow': 2.2,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 150230377,
 'forwardEps': -0.61,
 'forwardPE': -5.967213,
 'fromCurrency': None,
 'fullTimeEmployees': 404,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.043330003,
 'heldPercentInstitutions': 0.87943,
 'industry': 'Diagnostics & Research',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/pacb.com',
 'longBusinessSummary': 'Pacific Biosciences of California, Inc. designs, '
                        'develops, and manufactures sequencing systems to '
                        'resolve genetically complex problems. Its single '
                        'molecule real-time (SMRT) sequencing technology '
                        'enables single molecule real-time detection of '
                        'biological processes.The company also provides '
                        'consumable products, including SMRT cells, as well as '
                        'various reagent kits designed for specific workflow '
                        'such as template preparation to convert DNA into '
                        'SMRTbell double-stranded DNA library formats '
                        'including molecular biology reagents, such as ligase, '
                        'buffers and exonucleases. In addition, it provides '
                        'binding kits, such as modified DNA polymerase used to '
                        'bind SMRTbell libraries to the polymerase in '
                        'preparation for sequencing; and sequencing kits '
                        'comprises reagents required for on-instrument, '
                        'real-time sequencing, including the phospholinked '
                        'nucleotides. The company serves research '
                        'institutions; commercial laboratories; genome '
                        'centers; clinical, government, and academic '
                        'institutions; genomics service providers; '
                        'pharmaceutical companies; and agricultural companies. '
                        'It markets its products through a direct sales force '
                        'in North America and Europe, as well as through '
                        'distribution partners in Asia, Europe, the Middle '
                        'East, Africa, and Latin America. The company was '
                        'formerly known as Nanofluidics, Inc. and changed its '
                        'name to Pacific Biosciences of California, Inc. in '
                        '2005. Pacific Biosciences of California, Inc. was '
                        'founded in 2000 and is headquartered in Menlo Park, '
                        'California.',
 'longName': 'Pacific Biosciences of California, Inc.',
 'market': 'us_market',
 'marketCap': 560807552,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_11461617',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -52548000,
 'nextFiscalYearEnd': 1640908800,
 'open': 3.9,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': -0.25,
 'phone': '650 521 8000',
 'previousClose': 3.92,
 'priceHint': 4,
 'priceToBook': 9.285715,
 'priceToSalesTrailing12Months': 6.226767,
 'profitMargins': -0.58345,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 3.9,
 'regularMarketDayLow': 3.64,
 'regularMarketOpen': 3.9,
 'regularMarketPreviousClose': 3.92,
 'regularMarketPrice': 3.9,
 'regularMarketVolume': 1168996,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 154050000,
 'sharesPercentSharesOut': 0.1159,
 'sharesShort': 17852546,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 16273469,
 'shortName': 'Pacific Biosciences of Californ',
 'shortPercentOfFloat': 0.123900004,
 'shortRatio': 12.16,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'PACB',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.343,
 'twoHundredDayAverage': 3.735252,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'afbf9e1c-8320-3cad-8278-ee8ce023e356',
 'volume': 1168996,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.pacb.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '94025'}